GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 119 filers reported holding GERON CORP in Q4 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $275 | -99.8% | 85,806 | +48.1% | 0.02% | +75.0% |
| Q3 2022 | $136,000 | -33.3% | 57,919 | -61.3% | 0.01% | -20.0% |
| Q1 2022 | $204,000 | -78.9% | 149,764 | -78.2% | 0.02% | -84.0% |
| Q2 2021 | $969,000 | +1438.1% | 687,373 | +1795.2% | 0.09% | +754.5% |
| Q3 2020 | $63,000 | -19.2% | 36,269 | -36.6% | 0.01% | +37.5% |
| Q4 2019 | $78,000 | +4.0% | 57,251 | +6.9% | 0.01% | +100.0% |
| Q2 2019 | $75,000 | +11.9% | 53,560 | +31.7% | 0.00% | 0.0% |
| Q1 2019 | $67,000 | -64.4% | 40,654 | -78.4% | 0.00% | -60.0% |
| Q4 2018 | $188,000 | -62.2% | 188,290 | +60.8% | 0.01% | -63.0% |
| Q1 2018 | $498,000 | +1744.4% | 117,130 | +667.7% | 0.03% | +2600.0% |
| Q4 2017 | $27,000 | -88.2% | 15,257 | -85.4% | 0.00% | -90.9% |
| Q3 2017 | $229,000 | +397.8% | 104,843 | +883.8% | 0.01% | +175.0% |
| Q2 2015 | $46,000 | – | 10,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |